APA (7th ed.) Citation

Blauvelt, A., Gooderham, M., Griffiths, C. E. M., Armstrong, A. W., Zhu, B., Burge, R., . . . Lebwohl, M. (2022). Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: A Network Meta-Analysis. Dermatology & Therapy, 12(3), 727. https://doi.org/10.1007/s13555-022-00690-5

Chicago Style (17th ed.) Citation

Blauvelt, Andrew, et al. "Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: A Network Meta-Analysis." Dermatology & Therapy 12, no. 3 (2022): 727. https://doi.org/10.1007/s13555-022-00690-5.

MLA (9th ed.) Citation

Blauvelt, Andrew, et al. "Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: A Network Meta-Analysis." Dermatology & Therapy, vol. 12, no. 3, 2022, p. 727, https://doi.org/10.1007/s13555-022-00690-5.